Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Sponsor: Okuvision GmbH
Summary
Retinitis pigmentosa and similar degenerative diseases of the retina lead to progressive loss of vision. TES therapy with the CE-marked OkuStim® System is a treatment approved in the EU for slowing the progression of the disease. Patients increasingly report short-term subjective improvements in vision, which have not yet been systematically investigated. This exploratory study is conducted to determine whether these subjective short-term effects can be measured, and therefore also be quantified, by objective tests.
Official title: Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation (TES) on Visual Performance in Patients With Retinitis Pigmentosa and Similar Retinal Diseases
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-04
Completion Date
2027-03
Last Updated
2026-04-23
Healthy Volunteers
No
Interventions
Transcorneal Electrical Stimulation using the OkuStim System
Single application of the OkuStim® System for TES therapy in accordance with its intended purpose for 30 minutes. No control or comparative intervention planned.
Locations (1)
Augenzentrum Frankfurt Prof. Koch GmbH
Frankfurt am Main, Germany